Dolby Laboratories, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Dolby Laboratories, Inc. (DLB) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$52.44 million for the 3-month period ending 2019-12-27, per its 10-Q filed 2020-01-29.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2020-01-29
- Dolby Laboratories, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-12-27 was -$52.44M.
- Dolby Laboratories, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-12-28 was -$125.46M.
- Dolby Laboratories, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-12-29 was -$30.35M.
- Dolby Laboratories, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2019 was -$119.66M, a 141.14% decline from fiscal 2018.
- Dolby Laboratories, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was $290.88M, a 153.80% increase from fiscal 2017.
- Dolby Laboratories, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2017 was $114.61M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2019-12-27 | -$52.44M 10-Q · filed 2020-01-29 | |||
| 2019-09-27 | -$119.66M 10-K · filed 2019-11-25 | |||
| 2019-06-28 | -$201.21M 10-Q · filed 2019-08-02 | |||
| 2019-03-29 | -$190.38M 10-Q · filed 2019-05-08 | |||
| 2018-12-28 | -$125.46M 10-Q · filed 2020-01-29 | |||
| 2018-09-28 | $290.88M 10-K · filed 2019-11-25 | |||
| 2018-06-29 | $203.09M 10-Q · filed 2019-08-02 | |||
| 2018-03-30 | $79.23M 10-Q · filed 2019-05-08 | |||
| 2017-12-29 | -$30.35M 10-Q · filed 2019-02-01 | |||
| 2017-09-29 | $114.61M 10-K · filed 2019-11-25 |